Cooper Companies (NASDAQ:COO) Stock Rating Upgraded by Wall Street Zen

Cooper Companies (NASDAQ:COO) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Friday.

COO has been the subject of several other reports. Needham & Company LLC upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 price objective for the company in a report on Tuesday, June 17th. Piper Sandler restated an “overweight” rating and issued a $105.00 price objective (down from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Wells Fargo & Company decreased their price objective on Cooper Companies from $118.00 to $93.00 and set an “overweight” rating for the company in a report on Friday, May 30th. UBS Group upgraded Cooper Companies to a “buy” rating in a report on Tuesday, June 17th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $76.00 target price (down from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $99.70.

Cooper Companies Stock Up 2.1%

Shares of COO opened at $71.14 on Friday. The firm has a market capitalization of $14.23 billion, a P/E ratio of 34.53, a P/E/G ratio of 1.74 and a beta of 0.98. Cooper Companies has a 12-month low of $65.00 and a 12-month high of $112.38. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The firm has a fifty day moving average price of $76.42 and a 200-day moving average price of $84.02.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.03. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.85 earnings per share. Equities research analysts expect that Cooper Companies will post 3.98 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Zions Bancorporation National Association UT purchased a new stake in Cooper Companies during the first quarter worth $33,000. OFI Invest Asset Management acquired a new stake in Cooper Companies during the fourth quarter worth about $34,000. City Holding Co. acquired a new stake in Cooper Companies during the first quarter worth about $34,000. New Age Alpha Advisors LLC acquired a new stake in Cooper Companies during the fourth quarter worth about $38,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in Cooper Companies during the first quarter worth about $40,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.